The pathology, diagnosis, and treatment of the complex disorder, trichotillomania, is reviewed.
This clinical review assessed the use of exposure and response prevention therapy for patients with obsessive-compulsive disorder during the COVID-19 pandemic.
This study examines whether pretreatment brain activation during cognitive control and reward processing is associated with treatment response to CBT in patients with OCD.
In body dysmorphic disorder, the higher a patient’s readiness to change and confidence in cognitive behavioral therapy, the more likely the intervention will be successful.
Cognitive behavioral therapy and supportive psychotherapy can improve body dysmorphic disorder symptoms, but cognitive behavioral therapy is associated with more consistent improvements.
A study compared participants with clear diagnoses of either generalized anxiety disorder or obsessive-compulsive disorder with each other, as well as with controls, in order to identify cognitive differences between both groups.
Intensive residential treatment was found to be effective in reducing the symptoms of obsessive-compulsive disorder, although different response trajectories were observed.
Transcranial magnetic stimulation (TMS) uses magnetic fields to stimulate nerve cells in the brain.
Researchers examined whether adjunctive gabapentin or memantine and standard treatment with a selective serotonin-reuptake inhibitor (SSRI) might lead to further improvements in patients with OCD.
A brain stimulation device to treat OCD has received approval for marketing by the US Food and Drug Administration.